Cargando…

Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate

The versatility of natural killer cells has ignited growing interest in their therapeutic use for cancer and other immunotherapy treatments. However, NK cells compose a small portion of peripheral blood mononuclear cells (5%–20% of PBMCs) and clinical doses require billions of cells. Manufacturing s...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Christopher D. L., Zale, Nicole E., Frary, Eric D., Lomakin, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934851/
https://www.ncbi.nlm.nih.gov/pubmed/35320938
http://dx.doi.org/10.3389/fimmu.2022.803380
_version_ 1784671920099164160
author Johnson, Christopher D. L.
Zale, Nicole E.
Frary, Eric D.
Lomakin, Joseph A.
author_facet Johnson, Christopher D. L.
Zale, Nicole E.
Frary, Eric D.
Lomakin, Joseph A.
author_sort Johnson, Christopher D. L.
collection PubMed
description The versatility of natural killer cells has ignited growing interest in their therapeutic use for cancer and other immunotherapy treatments. However, NK cells compose a small portion of peripheral blood mononuclear cells (5%–20% of PBMCs) and clinical doses require billions of cells. Manufacturing suitable doses of NK cells remains a major challenge for NK immunotherapy. The current standard for expanding NK cells relies on feeder cells and fetal bovine serum to achieve large expansion, but both encounter regulatory concerns. We developed NK Cloudz, a dissolvable polymer-based microsphere platform, as an alternative to a feeder cell approach to expand NK cells. We demonstrated that a combination of NK Cloudz, a G-Rex6M culture vessel, and GMP Human Platelet Lysate expanded NK cells 387 ± 100-fold in 10 days from a PBMC starting population. The NK purity, viability, and cytotoxicity were similar to both a feeder cell protocol and an FBS-based protocol. Additionally, we found no significant differences between FBS and GMP Human Platelet Lysate and concluded that platelet lysate is a good xeno-free alternative to FBS for NK expansion. Overall, we demonstrated a feeder-cell-free and FBS-free protocol that leverages NK Cloudz as a promising step toward a commercial GMP manufacturing method to expand NK cells for therapeutic use.
format Online
Article
Text
id pubmed-8934851
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89348512022-03-22 Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate Johnson, Christopher D. L. Zale, Nicole E. Frary, Eric D. Lomakin, Joseph A. Front Immunol Immunology The versatility of natural killer cells has ignited growing interest in their therapeutic use for cancer and other immunotherapy treatments. However, NK cells compose a small portion of peripheral blood mononuclear cells (5%–20% of PBMCs) and clinical doses require billions of cells. Manufacturing suitable doses of NK cells remains a major challenge for NK immunotherapy. The current standard for expanding NK cells relies on feeder cells and fetal bovine serum to achieve large expansion, but both encounter regulatory concerns. We developed NK Cloudz, a dissolvable polymer-based microsphere platform, as an alternative to a feeder cell approach to expand NK cells. We demonstrated that a combination of NK Cloudz, a G-Rex6M culture vessel, and GMP Human Platelet Lysate expanded NK cells 387 ± 100-fold in 10 days from a PBMC starting population. The NK purity, viability, and cytotoxicity were similar to both a feeder cell protocol and an FBS-based protocol. Additionally, we found no significant differences between FBS and GMP Human Platelet Lysate and concluded that platelet lysate is a good xeno-free alternative to FBS for NK expansion. Overall, we demonstrated a feeder-cell-free and FBS-free protocol that leverages NK Cloudz as a promising step toward a commercial GMP manufacturing method to expand NK cells for therapeutic use. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8934851/ /pubmed/35320938 http://dx.doi.org/10.3389/fimmu.2022.803380 Text en Copyright © 2022 Johnson, Zale, Frary and Lomakin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Johnson, Christopher D. L.
Zale, Nicole E.
Frary, Eric D.
Lomakin, Joseph A.
Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title_full Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title_fullStr Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title_full_unstemmed Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title_short Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate
title_sort feeder-cell-free and serum-free expansion of natural killer cells using cloudz microspheres, g-rex6m, and human platelet lysate
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934851/
https://www.ncbi.nlm.nih.gov/pubmed/35320938
http://dx.doi.org/10.3389/fimmu.2022.803380
work_keys_str_mv AT johnsonchristopherdl feedercellfreeandserumfreeexpansionofnaturalkillercellsusingcloudzmicrospheresgrex6mandhumanplateletlysate
AT zalenicolee feedercellfreeandserumfreeexpansionofnaturalkillercellsusingcloudzmicrospheresgrex6mandhumanplateletlysate
AT fraryericd feedercellfreeandserumfreeexpansionofnaturalkillercellsusingcloudzmicrospheresgrex6mandhumanplateletlysate
AT lomakinjosepha feedercellfreeandserumfreeexpansionofnaturalkillercellsusingcloudzmicrospheresgrex6mandhumanplateletlysate